Fundz

Emmecell Appoints Ramin Valian as Chief Executive Officer

PRIVATEJan 16, 2026

Position

Chief Executive Officer

Company

Emmecell

Ramin Valian
ramin@emmecell.com
Menlo ParkBiotechnologyHealth CareTherapeutics

Description

Emmecell has appointed Ramin Valian as its new Chief Executive Officer. Valian, a seasoned biopharmaceutical executive, will lead the company's strategic initiatives as it advances its magnetic cell delivery technology.

Quick answer

Emmecell Appoints Ramin Valian as Chief Executive Officer (January 16, 2026). Emmecell is based in Menlo Park, California, United States.

Who is the new Chief Executive Officer at Emmecell?
Emmecell named Ramin Valian Chief Executive Officer, announced January 16, 2026.
What did Emmecell announce on January 16, 2026?
Emmecell has appointed Ramin Valian as its new Chief Executive Officer. Valian, a seasoned biopharmaceutical executive, will lead the company's strategic initiatives as it advances its magnetic cell delivery technology.
What does Emmecell do?
Emmecell is a clinical-stage biotechnology company developing magnetic cell delivery technologies to treat corneal disease, geographic atrophy, and other ophthalmic conditions.
Where is Emmecell based?
Emmecell is based in Menlo Park, California, United States.
Which similar companies made leadership changes around the same time?
Spyre Therapeutics (January 17, 2026), HaemaLogiX (January 15, 2026), Flashpoint Therapeutics (January 14, 2026) and Veristat (January 13, 2026) also announced leadership changes within 45 days of Emmecell.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Emmecell, and when

A new leader at Emmecell brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Emmecell raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Emmecell, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Emmecell. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Emmecell

Location

Menlo Park, California, United States

About

Emmecell is a clinical-stage biotechnology company developing magnetic cell delivery technologies to treat corneal disease, geographic atrophy, and other ophthalmic conditions. Its platform enables controlled, targeted positioning of therapeutic cells to support minimally invasive, regenerative alternatives to traditional surgical and pharmacologic therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Emmecell changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Noelia
Senior decision-maker at this company
••••••••@••••••••

See Noelia's verified email →

Cyril
Senior decision-maker at this company
••••••••@••••••••

See Cyril's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Emmecell's next move

Learn about Strategic plan

Emmecell changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.